Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Radiation Symptom Burden in Head and Neck Cancer
NCT01173692Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 2010
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute radiation syndrome (ARS) comparing Minocycline with Placebo (2 arms). Primary endpoint: Combined Area Under the Curve for Selected Patient Symptoms up to 7 weeks. Started Jul 2010; status: completed.
02
Drugs
minocycline
03
Conditions
acute radiation syndrome (ARS)
Beyond the preview
Go deeper on NCT01173692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01173692.